Vaccines aren’t the best at protecting against virus variants because they focus on a specific strain. According to a recent Medgadget article, a team of researchers at Northwestern University has a new strategy to fight the virus that is unlikely to be affected by changes in future variants. They discovered natural extracellular vesicles in the blood that act as a decoy binding site for viral particles and prevent them from binding to and infecting cells.
Anti-COVID Nanobubbles Block the Virus from Infecting Cells
The team behind the discovery hopes to develop the nanostructures into a nasal spray therapeutic to fight COVID-19.
Feb 2, 2022
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
